Physician profile
Donald B Hoffman
NPI 1578525069
$2,300.35
in general payments reported to CMS, 2019-2025
18 companies · $226 in 2025
The $226 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $530 · 2020: $190 · 2021: $587 · 2022: $196 · 2023: $399 · 2024: $172 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $797.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $408.29 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $336.05 | 2020-2024 | Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $245.32 | 2019-2025 | Ofev, Jascayd |
| Astellas Pharma US INC | $187.55 | 2021 | |
| Grifols USA, LLC | $169.31 | 2019-2024 | Prolastin-C Liquid |
| Insmed, INC. | $168.03 | 2019-2025 | Arikayce |
| United Therapeutics Corporation | $158.99 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $137.99 | 2023-2025 | Opsumit, Uptravi |
| Electromed, INC. | $117.34 | 2019-2024 | Smartvest |
| Mylan Specialty L.P. | $115.55 | 2021-2023 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $68.74 | 2021-2025 | Dupixent |
| Genzyme Corporation | $52.58 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $27.59 | 2025 | |
| Boston Scientific Corporation | $25.80 | 2022 | |
| Advanced Respiratory, INC | $23.09 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $22.35 | 2023 | Barostim Neo System |
| Philips North America LLC | $18.31 | 2025 | Vest Therapy Und |
| Genentech USA, INC. | $17.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.